• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OSTF1基因敲低通过抑制NF-κB信号通路减轻白细胞介素-1β诱导的软骨细胞损伤。

OSTF1 knockdown mitigates IL-1β-induced chondrocyte injury via inhibiting the NF-κB signaling pathway.

作者信息

Hu Bin, Du Gongwen

机构信息

Department of Hand and Foot Surgery, Yijishan Hospital of Wannan Medical College, No. 2, Zheshan West Road, Wuhu, Anhui, China.

Department of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, No. 218, Jixi Road, Hefei, Anhui, China.

出版信息

Heliyon. 2024 Apr 20;10(9):e30110. doi: 10.1016/j.heliyon.2024.e30110. eCollection 2024 May 15.

DOI:10.1016/j.heliyon.2024.e30110
PMID:38699012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11064439/
Abstract

Osteoarthritis (OA) is an age-related joint disease characterized by progressive heterogeneous changes in articular cartilage and subchondral bone. Osteoclast stimulating factor 1 (OSTF1) is a small intracellular protein involved in bone formation and bone resorption. However, to our best knowledge, its role in OA is still unclear. In this study, an OA rat model was established by anterior cruciate ligament transection (ALCT). OSTF1 was increased in the cartilage tissues of OA patients and OA rats. Next, the role of OSTF1 in interleukin-1β (IL-1β)-induced chondrocyte apoptosis, inflammation and extracellular matrix degradation was explored through loss of function assays. Strikingly, OSTF1 knockdown relieved IL-1β-induced chondrocyte apoptosis, with decreased cleaved caspase-3 and cleaved PARP levels. Besides, OSTF1 knockdown restrained IL-1β-induced inflammation and degradation of extracellular matrix of chondrocytes. Subsequently, the molecular mechanism of OSTF1 was explored. Transcriptomic analysis revealed the potential gene network map regulated by OSTF1 knockdown. Some differentially expressed genes (DEGs) were involved in regulating the NF-κB signaling pathway. Furthermore, our results demonstrated that OSTF1 knockdown inhibited IL-1β-activated the NF-κB signaling pathway. Ultimately, we analyzed the potential gene network map regulated by OSTF1 and its downstream NF-κB. Bioinformatics analysis showed that 18 DEGs in OSTF1-silenced chondrocytes overlapped with the NF-κB downstream targets. Collectively, our findings indicate that OSTF1 knockdown mitigates IL-1β-induced chondrocyte injury via inhibiting the NF-κB signaling pathway.

摘要

骨关节炎(OA)是一种与年龄相关的关节疾病,其特征是关节软骨和软骨下骨出现渐进性异质性变化。破骨细胞刺激因子1(OSTF1)是一种参与骨形成和骨吸收的小细胞内蛋白。然而,据我们所知,其在OA中的作用仍不清楚。在本研究中,通过切断前交叉韧带(ALCT)建立了OA大鼠模型。OA患者和OA大鼠的软骨组织中OSTF1增加。接下来,通过功能丧失实验探讨了OSTF1在白细胞介素-1β(IL-1β)诱导的软骨细胞凋亡、炎症和细胞外基质降解中的作用。令人惊讶的是,敲低OSTF1可减轻IL-1β诱导的软骨细胞凋亡,同时降低裂解的半胱天冬酶-3和裂解的PARP水平。此外,敲低OSTF1可抑制IL-1β诱导的软骨细胞炎症和细胞外基质降解。随后,探讨了OSTF1的分子机制。转录组分析揭示了敲低OSTF1所调控的潜在基因网络图。一些差异表达基因(DEGs)参与调节NF-κB信号通路。此外,我们的结果表明,敲低OSTF1可抑制IL-1β激活NF-κB信号通路。最终,我们分析了由OSTF1及其下游NF-κB调控的潜在基因网络图。生物信息学分析表明,OSTF1沉默的软骨细胞中有18个DEGs与NF-κB下游靶点重叠。总的来说,我们的研究结果表明,敲低OSTF1可通过抑制NF-κB信号通路减轻IL-1β诱导的软骨细胞损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/d8d002a591ad/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/faacf3cd79a9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/0b0ef53311b9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/3ba952bffe66/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/856e6d0ad26f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/4c1e28e14c9b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/9197195629cd/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/dd2401318bd0/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/d2d87c53318b/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/15d9f71e597f/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/d8d002a591ad/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/faacf3cd79a9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/0b0ef53311b9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/3ba952bffe66/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/856e6d0ad26f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/4c1e28e14c9b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/9197195629cd/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/dd2401318bd0/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/d2d87c53318b/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/15d9f71e597f/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9198/11064439/d8d002a591ad/mmcfigs1.jpg

相似文献

1
OSTF1 knockdown mitigates IL-1β-induced chondrocyte injury via inhibiting the NF-κB signaling pathway.OSTF1基因敲低通过抑制NF-κB信号通路减轻白细胞介素-1β诱导的软骨细胞损伤。
Heliyon. 2024 Apr 20;10(9):e30110. doi: 10.1016/j.heliyon.2024.e30110. eCollection 2024 May 15.
2
Silencing BLNK protects against interleukin-1β-induced chondrocyte injury through the NF-κB signaling pathway.沉默 BLNK 通过 NF-κB 信号通路保护白细胞介素-1β诱导的软骨细胞损伤。
Cytokine. 2021 Dec;148:155686. doi: 10.1016/j.cyto.2021.155686. Epub 2021 Sep 11.
3
Polydatin inhibits IL-1β-mediated chondrocyte inflammation and ameliorates cartilage degradation: Involvement of the NF-κB and Wnt/β-catenin pathways.虎杖苷抑制 IL-1β 介导的软骨细胞炎症并改善软骨降解:涉及 NF-κB 和 Wnt/β-连环蛋白通路。
Tissue Cell. 2022 Oct;78:101865. doi: 10.1016/j.tice.2022.101865. Epub 2022 Jul 16.
4
Circ_0008365 Suppresses Apoptosis, Inflammation and Extracellular Matrix Degradation of IL-1β-treated Chondrocytes in Osteoarthritis by Regulating miR-324-5p/BMPR2/NF-κB Signaling Axis.环状 RNA 0008365 通过调控 miR-324-5p/BMPR2/NF-κB 信号轴抑制白细胞介素-1β诱导的骨关节炎软骨细胞凋亡、炎症和细胞外基质降解。
Immunol Invest. 2022 Aug;51(6):1598-1611. doi: 10.1080/08820139.2021.2001496. Epub 2022 Feb 17.
5
[Ligusticum cycloprolactam inhibits IL-1β-induced apoptosis and inflammation of rat chondrocytes via HMGB1/TLR4/NF-κB signaling pathway].[环丙基内酰胺川芎抑制大鼠软骨细胞中白细胞介素-1β诱导的细胞凋亡和炎症,通过高迁移率族蛋白B1/ Toll样受体4/核因子κB信号通路]
Zhongguo Zhong Yao Za Zhi. 2024 Feb;49(4):1007-1016. doi: 10.19540/j.cnki.cjcmm.20230904.401.
6
Isoliquiritigenin suppresses IL-1β induced apoptosis and inflammation in chondrocyte-like ATDC5 cells by inhibiting NF-κB and exerts chondroprotective effects on a mouse model of anterior cruciate ligament transection.异甘草素通过抑制核因子κB抑制白细胞介素-1β诱导的软骨样ATDC5细胞凋亡和炎症,并对前交叉韧带横断小鼠模型发挥软骨保护作用。
Int J Mol Med. 2017 Dec;40(6):1709-1718. doi: 10.3892/ijmm.2017.3177. Epub 2017 Oct 9.
7
CircTBX5 knockdown modulates the miR-558/MyD88 axis to alleviate IL-1β-induced inflammation, apoptosis and extracellular matrix degradation in chondrocytes via inactivating the NF-κB signaling.CircTBX5 敲低通过使 NF-κB 信号失活来调节 miR-558/MyD88 轴,从而减轻软骨细胞中由 IL-1β 诱导的炎症、凋亡和细胞外基质降解。
J Orthop Surg Res. 2023 Jul 1;18(1):477. doi: 10.1186/s13018-023-03949-5.
8
CHMP5 attenuates osteoarthritis via inhibiting chondrocyte apoptosis and extracellular matrix degradation: involvement of NF-κB pathway.CHMP5 通过抑制软骨细胞凋亡和细胞外基质降解来减轻骨关节炎:涉及 NF-κB 通路。
Mol Med. 2024 Apr 25;30(1):55. doi: 10.1186/s10020-024-00819-6.
9
Calycosin mitigates chondrocyte inflammation and apoptosis by inhibiting the PI3K/AKT and NF-κB pathways.毛蕊异黄酮通过抑制 PI3K/AKT 和 NF-κB 通路减轻软骨细胞炎症和凋亡。
J Ethnopharmacol. 2022 Oct 28;297:115536. doi: 10.1016/j.jep.2022.115536. Epub 2022 Jul 14.
10
Enhancement of DUSP14 (dual specificity phosphatase 14) limits osteoarthritis progression by alleviating chondrocyte injury, inflammation and metabolic homeostasis.双特异性磷酸酶 14(DUSP14)的增强通过减轻软骨细胞损伤、炎症和代谢平衡来限制骨关节炎的进展。
Bioengineered. 2021 Dec;12(1):7495-7507. doi: 10.1080/21655979.2021.1979355.

本文引用的文献

1
LONP1 downregulation with ageing contributes to osteoarthritis via mitochondrial dysfunction.LONP1 的下调随年龄增长而发生,通过线粒体功能障碍导致骨关节炎。
Free Radic Biol Med. 2022 Oct;191:176-190. doi: 10.1016/j.freeradbiomed.2022.08.038. Epub 2022 Sep 3.
2
Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage.青蒿素通过降低 TNFSF11 表达和抑制软骨中 PI3K/AKT/mTOR 信号通路激活线粒体自噬缓解骨关节炎。
Cell Mol Biol Lett. 2022 Jul 28;27(1):62. doi: 10.1186/s11658-022-00365-1.
3
KLF4, negatively regulated by miR-7, suppresses osteoarthritis development via activating TGF-β1 signaling.
KLF4 通过激活 TGF-β1 信号通路抑制骨关节炎的发展,其表达受 miR-7 负调控。
Int Immunopharmacol. 2022 Jan;102:108416. doi: 10.1016/j.intimp.2021.108416. Epub 2021 Dec 8.
4
Single-cell rna seq analysis identifies the biomarkers and differentiation of chondrocyte in human osteoarthritis.单细胞RNA测序分析确定人类骨关节炎中软骨细胞的生物标志物和分化情况。
Am J Transl Res. 2020 Nov 15;12(11):7326-7339. eCollection 2020.
5
Down-regulated ciRS-7/up-regulated miR-7 axis aggravated cartilage degradation and autophagy defection by PI3K/AKT/mTOR activation mediated by IL-17A in osteoarthritis.下调的 ciRS-7/上调的 miR-7 轴通过 IL-17A 介导的 PI3K/AKT/mTOR 激活加重骨关节炎中的软骨降解和自噬缺陷。
Aging (Albany NY). 2020 Oct 25;12(20):20163-20183. doi: 10.18632/aging.103731.
6
SH3P2 suppresses osteoclast differentiation through restricting membrane localization of myosin 1E.SH3P2 通过限制肌球蛋白 1E 的膜定位来抑制破骨细胞分化。
Genes Cells. 2020 Nov;25(11):707-717. doi: 10.1111/gtc.12806. Epub 2020 Oct 7.
7
NF-ĸβ upregulates ADAMTS5 expression by direct binding after TNF-α treatment in OUMS-27 chondrosarcoma cell line.NF-κβ 通过 TNF-α 处理后直接结合上调 OUMS-27 软骨肉瘤细胞系中 ADAMTS5 的表达。
Mol Biol Rep. 2020 Jun;47(6):4215-4223. doi: 10.1007/s11033-020-05514-3. Epub 2020 May 15.
8
Effect of Lubricin Mimetics on the Inhibition of Osteoarthritis in a Rat Anterior Cruciate Ligament Transection Model.黏蛋白类似物对大鼠前交叉韧带切断模型骨关节炎抑制作用的影响。
Am J Sports Med. 2020 Mar;48(3):624-634. doi: 10.1177/0363546519898691. Epub 2020 Jan 31.
9
Early Alterations of Subchondral Bone in the Rat Anterior Cruciate Ligament Transection Model of Osteoarthritis.骨关节炎大鼠前交叉韧带切断模型中软骨下骨的早期改变。
Cartilage. 2021 Dec;13(2_suppl):1322S-1333S. doi: 10.1177/1947603519878479. Epub 2019 Sep 30.
10
Osteoarthritis.骨关节炎。
Lancet. 2019 Apr 27;393(10182):1745-1759. doi: 10.1016/S0140-6736(19)30417-9.